English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biogen
Bree Gonzales
| Jun 9, 2021
Biogen gets FDA approval for Alzheimer's treatment: 'the first therapy to target the underlying disease process'
Carrie Bradon
| Nov 30, 2017
Biogen names new chief financial officer
Carrie Bradon
| Nov 27, 2017
Biogen to present at conference this month
Nicholas Gueguen
| Jun 11, 2017
European Commission OKs Spinraza to fight spinal muscular atrophy
Jeff Gantt
| Dec 14, 2016
Biogen presents PRIME study data at clinical trials meeting
Amanda Rupp
| Sep 16, 2016
New data for Zinbryta support long-term safety profile
Amanda Rupp
| Aug 12, 2016
Biogen launches new company dedicated to hemophilia
Amanda Rupp
| Jun 23, 2016
McKenzie named new Biogen executive vice president
Trending
Patient Daily
| Aug 12, 2025
Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+
Pharmaceuticals
Patient Daily
| Aug 18, 2025
Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+
Regulatory
Patient Daily
| Aug 14, 2025
Founder of Policy Candy: '340B must see comprehensive reforms'
+
Pharmaceuticals
Patient Daily
| Aug 14, 2025
PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'
